Sign in

NCT07082933Not yet recruiting

Long-term Survival and Influencing Factors of Patients With Pulmonary Arterial Hypertension and Diabetes

Long-term Survival and Influencing Factors of Patients With Pulmonary Arterial Hypertension and diabetes-a Multicenter Retrospective Cohort Study

Source: ClinicalTrials.gov · Last updated 24 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This is a multicenter retrospective cohort study on pulmonary arterial hypertension. It is expected to collect data from no less than 5,000 patients to compare the long-term overall survival of patients with and without diabetes, and analysis the risk factors of the overall survival .

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
5000 (estimated)
First submitted
16 Jul 2025
Start date
1 Aug 2025
Primary completion date
1 Aug 2027
Lead sponsor
Xijing Hospital
NCT number
NCT07082933

What you commit to

  • Study type: Observational
  • Planned participants: 5000
  • From 1 Aug 2025 to the primary completion date, 1 Aug 2027
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with malignant tumors.
  • Other physical conditions judged by the researchers as making the patients ineligible to participate in the clinical study.

Who the study is looking for

  • Individuals aged 18 to 80 years with full capacity for civil conduct.
  • Patients diagnosed with pulmonary hypertension by community-level and/or higher-level medical institutions.

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.